ArticleBMC public health2025
Prevalence of hypothyroidism among patients undergoing thyroid function tests in primary healthcare centres in Dubai, UAE.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Epidemiological Patterns and Determinants of Subclinical and Overt Hypothyroidism in a Clinical Cohort from the Hail Region, Saudi Arabia: A Retrospective Cross-Sectional and Cluster Analysis Study.Clinics and practice · 2026Article
- Retrospective analysis of thyroid functions and sonographic characteristics of the thyroid gland in a health check-up population in China during 2020-2024.Frontiers in public health · 2026Article
- Assessment of sleep quality and hypothyroidism among medical students in India.Bioinformation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHypothyroidism is a common disorder worldwide with a varied prevalence. Limited data are available on the prevalence rates of hypothyroidism in the Middle East and North Africa (MENA) region, particularly the United Arab Emirates (UAE). This study aimed to evaluate the prevalence and associated factors of hypothyroidism among adult patients visiting primary healthcare centres (PHC) in Dubai, UAE.
methodsA retrospective study was conducted using data from a registry maintained at the PHC of Dubai Health, from January 1, 2018, to December 31, 2020. The study included adults with thyroid function test (TFT) results and an International Classification of Diseases (ICD) 10 codes indicating hypothyroidism or subclinical hypothyroidism. Descriptive statistics were analysed for continuous and categorical variables, such as age, body mass index (BMI) and overweight or obese status. Chi-square and t-tests were employed to identify associations and differences between variables among individuals with and without hypothyroidism. The p-value ≤ 0.05 was considered statistically significant.
resultsA total of 77,758 adult patients was analysed; among them, 49,995 (64.3%) were females and 27,762 (35.7%) were males; data was missing for 1 patient. The median age was 42 years, with a median BMI of 28.41. The overall prevalence of hypothyroidism was 2.1%, consisting of 91.4% overt hypothyroidism and 8.6% subclinical hypothyroidism. It was significantly higher in females (81.5%) than in males (18.5%). The highest prevalence (2.52%) was found in adults aged 35-44 years. Nearly half of the patients with hypothyroidism were obese (47%), followed by patients who were overweight (33.9%). Among patients with hypothyroidism, 0.73% had type 1 diabetes mellitus and no co-diagnoses of other autoimmune diseases; comorbidities included dyslipidemia (8%), hypertension (6.5%) and ischemic heart disease (1%).
conclusionThe study revealed that hypothyroidism is common among patients visiting PHC in Dubai, with a prevalence rate similar to those reported in Europe and North America (0.3%-5.3%), but much lower than that in neighbouring Gulf countries, such as Bahrain (44%), Saudi Arabia (29%) and Jordan (26%). Moreover, the highest prevalence of hypothyroidism is found among young and middle-aged individuals, particularly women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.